(Q40723532)

23 September 2017

Antiviral activity of Plantago major extracts and related compounds in vitro (English)

1 reference

23 September 2017

2 references

1 reference

1 reference

1 reference

1 reference

1 reference

Chiang LC

1

1 reference

23 September 2017

Chiang W

2

1 reference

23 September 2017

Chang MY

3

1 reference

23 September 2017

Ng LT

4

1 reference

23 September 2017

Lin CC

5

1 reference

23 September 2017

July 2002

3 references

16 September 2022

16 September 2022

1 reference

23 September 2017

55

1 reference

23 September 2017

53-62

1 reference

23 September 2017

1

1 reference

In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Viral etiology in acute lower respiratory infections in children from a closed community.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral activity of lignans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Inhibition of growth of human immunodeficiency virus in vitro by crude extracts of Chinese medicinal herbs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Treatment of adenovirus infection of the eye with 5-iodo-2'-deoxyuridine. A double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Fatal pneumonia associated with adenovirus type 7 in three military trainees

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral and antiphlogistic activities of Hamamelis virginiana bark

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

In vitro activity of a Combretum micranthum extract against herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Herpes simplex virus antiviral drug resistance--current trends and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Adenovirus cholecystitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Anti-herpes virus activity of Solanum steroidal glycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Medicinal plants used for the treatment of hepatitis in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral activities of biflavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral screening of British Columbian medicinal plants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Inhibitory activity of 3'-fluoro-2' deoxythymidine and related nucleoside analogues against adenoviruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Poly(Hydroxy)Carboxylates as Selective Inhibitors of Cytomegalovirus and Herpes Simplex Virus Replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

The traditional uses, chemical constituents and biological activities of Plantago major L. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Evaluation of Biological Activities of Triterpenoid Saponins fromMaesalanceolata†

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Inhibition of adenovirus infection with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral therapy of herpes simplex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Adenovirus Type 7b in a Children's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Antiviral Properties of Garlic: In vitro Effects on Influenza B, Herpes Simplex and Coxsackie Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

Herpes simplex virus infections of women and their offspring: implications for a developed society

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

1 reference

7 January 2021

Adenovirus infection in the immunocompromised patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900007-4

7 January 2021

10.1016/S0166-3542(02)00007-4

Identifiers

DOI

1 reference

23 September 2017

1 reference